Nutrient Availability as a Mechanism for Selection of Antibiotic Tolerant within the CF Airway
Microbes are subjected to selective pressures during chronic infections of host tissues. Pseudomonas aeruginosa isolates with inactivating mutations in the transcriptional regulator LasR are frequently selected within the airways of people with cystic fibrosis (CF), and infection with these isolates has been associated with poorer lung function outcomes. The mechanisms underlying selection for lasR mutation are unknown but have been postulated to involve the abundance of specific nutrients within CF airway secretions. We characterized lasR mutant P. aeruginosa strains and isolates to identify conditions found in CF airways that select for growth of lasR mutants. Relative to wild-type P. aeruginosa, lasR mutants exhibited a dramatic metabolic shift, including decreased oxygen consumption and increased nitrate utilization, that is predicted to confer increased fitness within the nutrient conditions known to occur in CF airways. This metabolic shift exhibited by lasR mutants conferred resistance to two antibiotics used frequently in CF care, tobramycin and ciprofloxacin, even under oxygen-dependent growth conditions, yet selection for these mutants in vitro did not require preceding antibiotic exposure. The selection for loss of LasR function in vivo, and the associated adverse clinical impact, could be due to increased bacterial growth in the oxygen-poor and nitrate-rich CF airway, and from the resulting resistance to therapeutic antibiotics. The metabolic similarities among diverse chronic infection-adapted bacteria suggest a common mode of adaptation and antibiotic resistance during chronic infection that is primarily driven by bacterial metabolic shifts in response to nutrient availability within host tissues.
Vyšlo v časopise:
Nutrient Availability as a Mechanism for Selection of Antibiotic Tolerant within the CF Airway. PLoS Pathog 6(1): e32767. doi:10.1371/journal.ppat.1000712
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000712
Souhrn
Microbes are subjected to selective pressures during chronic infections of host tissues. Pseudomonas aeruginosa isolates with inactivating mutations in the transcriptional regulator LasR are frequently selected within the airways of people with cystic fibrosis (CF), and infection with these isolates has been associated with poorer lung function outcomes. The mechanisms underlying selection for lasR mutation are unknown but have been postulated to involve the abundance of specific nutrients within CF airway secretions. We characterized lasR mutant P. aeruginosa strains and isolates to identify conditions found in CF airways that select for growth of lasR mutants. Relative to wild-type P. aeruginosa, lasR mutants exhibited a dramatic metabolic shift, including decreased oxygen consumption and increased nitrate utilization, that is predicted to confer increased fitness within the nutrient conditions known to occur in CF airways. This metabolic shift exhibited by lasR mutants conferred resistance to two antibiotics used frequently in CF care, tobramycin and ciprofloxacin, even under oxygen-dependent growth conditions, yet selection for these mutants in vitro did not require preceding antibiotic exposure. The selection for loss of LasR function in vivo, and the associated adverse clinical impact, could be due to increased bacterial growth in the oxygen-poor and nitrate-rich CF airway, and from the resulting resistance to therapeutic antibiotics. The metabolic similarities among diverse chronic infection-adapted bacteria suggest a common mode of adaptation and antibiotic resistance during chronic infection that is primarily driven by bacterial metabolic shifts in response to nutrient availability within host tissues.
Zdroje
1. GiannakisM
ChenSL
KaramSM
EngstrandL
GordonJI
2008 Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Proc Natl Acad Sci U S A 105 4358 4363
2. SmithEE
BuckleyDG
WuZ
SaenphimmachakC
HoffmanLR
2006 Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103 8487 8492
3. GovanJR
DereticV
1996 Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60 539 574
4. MahenthiralingamE
CampbellME
SpeertDP
1994 Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 62 596 605
5. ErnstRK
AdamsKN
MoskowitzSM
KraigGM
KawasakiK
2006 The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway. J Bacteriol 188 191 201
6. BurnsJL
Van DalfsenJM
ShawarRM
OttoKL
GarberRL
1999 Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J Infect Dis 179 1190 1196
7. LiZ
KosorokMR
FarrellPM
LaxovaA
WestSE
2005 Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. Jama 293 581 588
8. HoffmanLR
KulasekaraHD
EmersonJ
HoustonLS
BurnsJL
2009 Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. J Cyst Fibros 8 66 70
9. GibsonRL
EmersonJ
Mayer-HamblettN
BurnsJL
McNamaraS
2007 Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Pediatr Pulmonol 42 610 623
10. SalunkheP
SmartCH
MorganJA
PanageaS
WalshawMJ
2005 A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. J Bacteriol 187 4908 4920
11. D'ArgenioDA
WuM
HoffmanLR
KulasekaraHD
DezielE
2007 Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol 64 512 533
12. TingpejP
SmithL
RoseB
ZhuH
ConibearT
2007 Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis. J Clin Microbiol 45 1697 1704
13. BarthAL
PittTL
1996 The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J Med Microbiol 45 110 119
14. WagnerVE
BushnellD
PassadorL
BrooksAI
IglewskiBH
2003 Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment. J Bacteriol 185 2080 2095
15. ToyofukuM
NomuraN
FujiiT
TakayaN
MasedaH
2007 Quorum sensing regulates denitrification in Pseudomonas aeruginosa PAO1. J Bacteriol 189 4969 4972
16. YoonSS
HenniganRF
HilliardGM
OchsnerUA
ParvatiyarK
2002 Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell 3 593 603
17. PalmerKL
BrownSA
WhiteleyM
2007 Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum. J Bacteriol 189 4449 4455
18. GrasemannH
IoannidisI
TomkiewiczRP
de GrootH
RubinBK
1998 Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child 78 49 53
19. GrasemannH
KurtzF
RatjenF
2006 Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis. Am J Respir Crit Care Med 174 208 212
20. WorlitzschD
TarranR
UlrichM
SchwabU
CekiciA
2002 Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109 317 325
21. ChenF
XiaQ
JuLK
2006 Competition between oxygen and nitrate respirations in continuous culture of Pseudomonas aeruginosa performing aerobic denitrification. Biotechnol Bioeng 93 1069 1078
22. KohanskiMA
DwyerDJ
HayeteB
LawrenceCA
CollinsJJ
2007 A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130 797 810
23. BryanLE
1985 Antibiotic uptake and the cytoplasmic membrane. Antibiot Chemother 36 103 110
24. RichardsonAR
DunmanPM
FangFC
2006 The nitrosative stress response of Staphylococcus aureus is required for resistance to innate immunity. Mol Microbiol 61 927 939
25. AraiH
HayashiM
KuroiA
IshiiM
IgarashiY
2005 Transcriptional regulation of the flavohemoglobin gene for aerobic nitric oxide detoxification by the second nitric oxide-responsive regulator of Pseudomonas aeruginosa. J Bacteriol 187 3960 3968
26. RichardsonAR
LibbySJ
FangFC
2008 A nitric oxide-inducible lactate dehydrogenase enables Staphylococcus aureus to resist innate immunity. Science 319 1672 1676
27. YoonSS
CoakleyR
LauGW
LymarSV
GastonB
2006 Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J Clin Invest 116 436 446
28. KlausenM
HoffmanLR
D'ArgenioDA
Tolker-NielsenT
MillerSI
2005 In vitro Interactions Between Pseudomonas aeruginosa and Staphylococcus aureus. Proceedings: 10th International Congress on Pseudomonas
29. HoffmanLR
DezielE
D'ArgenioDA
LepineF
EmersonJ
2006 Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 103 19890 19895
30. SchusterM
LostrohCP
OgiT
GreenbergEP
2003 Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. J Bacteriol 185 2066 2079
31. HassettDJ
SchweizerHP
OhmanDE
1995 Pseudomonas aeruginosa sodA and sodB mutants defective in manganese- and iron-cofactored superoxide dismutase activity demonstrate the importance of the iron-cofactored form in aerobic metabolism. J Bacteriol 177 6330 6337
32. RobinsonKM
JanesMS
PeharM
MonetteJS
RossMF
2006 Selective fluorescent imaging of superoxide in vivo using ethidium-based probes. Proc Natl Acad Sci U S A 103 15038 15043
33. BaderMW
NavarreWW
ShiauW
NikaidoH
FryeJG
2003 Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. Mol Microbiol 50 219 230
34. ZhangL
DhillonP
YanH
FarmerS
HancockRE
2000 Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob Agents Chemother 44 3317 3321
35. HassettDJ
CharnigaL
BeanK
OhmanDE
CohenMS
1992 Response of Pseudomonas aeruginosa to pyocyanin: mechanisms of resistance, antioxidant defenses, and demonstration of a manganese-cofactored superoxide dismutase. Infect Immun 60 328 336
36. HassettDJ
AlsabbaghE
ParvatiyarK
HowellML
WilmottRW
2000 A protease-resistant catalase, KatA, released upon cell lysis during stationary phase is essential for aerobic survival of a Pseudomonas aeruginosa oxyR mutant at low cell densities. J Bacteriol 182 4557 4563
37. WangX
ZhaoX
2009 Contribution of oxidative damage to antimicrobial lethality. Antimicrob Agents Chemother 53 1395 1402
38. HausslerS
BeckerT
2008 The pseudomonas quinolone signal (PQS) balances life and death in Pseudomonas aeruginosa populations. PLoS Pathog 4 e1000166 doi:10.1371/journal.ppat.1000166
39. AlbesaI
BecerraMC
BattanPC
PaezPL
2004 Oxidative stress involved in the antibacterial action of different antibiotics. Biochem Biophys Res Commun 317 605 609
40. O'ReganE
QuinnT
PagesJM
McCuskerM
PiddockL
2009 Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators. Antimicrob Agents Chemother 53 1080 1087
41. GibsonRL
BurnsJL
RamseyBW
2003 Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168 918 951
42. GusarovI
ShatalinK
StarodubtsevaM
NudlerE
2009 Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics. Science 325 1380 1384
43. Alvarez-OrtegaC
HarwoodCS
2007 Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Mol Microbiol 65 153 165
44. TunneyMM
FieldTR
MoriartyTF
PatrickS
DoeringG
2008 Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 177 995 1001
45. WuH
SongZ
GivskovM
DoringG
WorlitzschD
2001 Pseudomonas aeruginosa mutations in lasI and rhlI quorum sensing systems result in milder chronic lung infection. Microbiology 147 1105 1113
46. TummlerB
BosshammerJ
BreitensteinS
BrockhausenI
GudowiusP
1997 Infections with Pseudomonas aeruginosa in patients with cystic fibrosis. Behring Inst Mitt 249 255
47. DiggleSP
CornelisP
WilliamsP
CamaraM
2006 4-quinolone signalling in Pseudomonas aeruginosa: old molecules, new perspectives. Int J Med Microbiol 296 83 91
48. LedghamF
VentreI
SosciaC
FoglinoM
SturgisJN
2003 Interactions of the quorum sensing regulator QscR: interaction with itself and the other regulators of Pseudomonas aeruginosa LasR and RhlR. Mol Microbiol 48 199 210
49. LiW
LuCD
2007 Regulation of carbon and nitrogen utilization by CbrAB and NtrBC two-component systems in Pseudomonas aeruginosa. J Bacteriol 189 5413 5420
50. BenovL
FridovichI
1999 Why superoxide imposes an aromatic amino acid auxotrophy on Escherichia coli. The transketolase connection. J Biol Chem 274 4202 4206
51. FinkRM
ElstnerEF
1984 Studies on the possible mechanism of inactivation of phenylalanine hydroxylase by destructive oxygen species. Z Naturforsch [C] 39 734 737
52. DezielE
LepineF
MilotS
HeJ
MindrinosMN
2004 Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2-heptylquinoline in cell-to-cell communication. Proc Natl Acad Sci U S A 101 1339 1344
53. ZhuH
BandaraR
ConibearTC
ThuruthyilSJ
RiceSA
2004 Pseudomonas aeruginosa with lasI quorum-sensing deficiency during corneal infection. Invest Ophthalmol Vis Sci 45 1897 1903
54. FothergillJL
PanageaS
HartCA
WalshawMJ
PittTL
2007 Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain. BMC Microbiol 7 45
55. LujanAM
MoyanoAJ
SeguraI
ArgaranaCE
SmaniaAM
2007 Quorum-sensing-deficient (lasR) mutants emerge at high frequency from a Pseudomonas aeruginosa mutS strain. Microbiology 153 225 237
56. HeurlierK
DenervaudV
HaenniM
GuyL
KrishnapillaiV
2005 Quorum-sensing-negative (lasR) mutants of Pseudomonas aeruginosa avoid cell lysis and death. J Bacteriol 187 4875 4883
57. DenervaudV
TuQuocP
BlancD
Favre-BonteS
KrishnapillaiV
2004 Characterization of cell-to-cell signaling-deficient Pseudomonas aeruginosa strains colonizing intubated patients. J Clin Microbiol 42 554 562
58. CabrolS
OlliverA
PierGB
AndremontA
RuimyR
2003 Transcription of quorum-sensing system genes in clinical and environmental isolates of Pseudomonas aeruginosa. J Bacteriol 185 7222 7230
59. SandozKM
MitzimbergSM
SchusterM
2007 Social cheating in Pseudomonas aeruginosa quorum sensing. Proc Natl Acad Sci U S A 104 15876 15881
60. DiggleSP
GriffinAS
CampbellGS
WestSA
2007 Cooperation and conflict in quorum-sensing bacterial populations. Nature 450 411 414
61. DekimpeV
DezielE
2009 Revisiting the quorum-sensing hierarchy in Pseudomonas aeruginosa: the transcriptional regulator RhlR regulates LasR-specific factors. Microbiology 155 712 723
62. MaJF
HagerPW
HowellML
PhibbsPV
HassettDJ
1998 Cloning and characterization of the Pseudomonas aeruginosa zwf gene encoding glucose-6-phosphate dehydrogenase, an enzyme important in resistance to methyl viologen (paraquat). J Bacteriol 180 1741 1749
63. Silo-SuhL
SuhSJ
PhibbsPV
OhmanDE
2005 Adaptations of Pseudomonas aeruginosa to the cystic fibrosis lung environment can include deregulation of zwf, encoding glucose-6-phosphate dehydrogenase. J Bacteriol 187 7561 7568
64. KohlerC
von EiffC
LiebekeM
McNamaraPJ
LalkM
2008 A defect in menadione biosynthesis induces global changes in gene expression in Staphylococcus aureus. J Bacteriol 190 6351 6364
65. von EiffC
McNamaraP
BeckerK
BatesD
LeiXH
2006 Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colony-variant phenotype. J Bacteriol 188 687 693
66. BoshoffHI
BarryCE3rd
2005 Tuberculosis - metabolism and respiration in the absence of growth. Nat Rev Microbiol 3 70 80
67. HuG
ChengPY
ShamA
PerfectJR
KronstadJW
2008 Metabolic adaptation in Cryptococcus neoformans during early murine pulmonary infection. Mol Microbiol
68. BrykR
GoldB
VenugopalA
SinghJ
SamyR
2008 Selective killing of nonreplicating mycobacteria. Cell Host Microbe 3 137 145
69. LiberatiNT
UrbachJM
MiyataS
LeeDG
DrenkardE
2006 An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci U S A 103 2833 2838
70. HoangTT
Karkhoff-SchweizerRR
KutchmaAJ
SchweizerHP
1998 A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212 77 86
71. WeissB
2001 Endonuclease V of Escherichia coli prevents mutations from nitrosative deamination during nitrate/nitrite respiration. Mutat Res 461 301 309
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 1
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Panton-Valentine Leukocidin Is a Very Potent Cytotoxic Factor for Human Neutrophils
- CD8+ T Cell Control of HIV—A Known Unknown
- Polyoma Virus-Induced Osteosarcomas in Inbred Strains of Mice: Host Determinants of Metastasis
- The Deadly Chytrid Fungus: A Story of an Emerging Pathogen